BR100 Decreased By (-0.73%)
BR30 Decreased By (-0.52%)
KSE100 Decreased By (-0.56%)
KSE30 Decreased By (-0.65%)
AGHA 7.69 Decreased By ▼ -0.12 (-1.54%)
BECO 5.16 Decreased By ▼ -0.05 (-0.96%)
BML 57.50 No Change ▼ 0.00 (0%)
BOP 34.10 Increased By ▲ 0.07 (0.21%)
CNERGY 10.05 Increased By ▲ 0.09 (0.9%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 53.70 Decreased By ▼ -1.00 (-1.83%)
FFL 16.56 Decreased By ▼ -0.13 (-0.78%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 7.26 Decreased By ▼ -0.14 (-1.89%)
KOSM 5.77 No Change ▼ 0.00 (0%)
LOTCHEM 29.20 Decreased By ▼ -0.12 (-0.41%)
MLCF 92.32 Decreased By ▼ -2.04 (-2.16%)
NBP 201.50 Decreased By ▼ -1.55 (-0.76%)
NCPL 56.67 Decreased By ▼ -0.33 (-0.58%)
NPL 67.00 Decreased By ▼ -0.70 (-1.03%)
OGDC 315.50 Decreased By ▼ -0.34 (-0.11%)
PACE 10.63 Decreased By ▼ -0.01 (-0.09%)
PAEL 42.70 Decreased By ▼ -0.50 (-1.16%)
PIBTL 16.60 Decreased By ▼ -0.14 (-0.84%)
PPL 218.40 Decreased By ▼ -1.38 (-0.63%)
PRL 51.10 Increased By ▲ 1.91 (3.88%)
PTC 70.21 Decreased By ▼ -0.32 (-0.45%)
SSGC 27.39 Decreased By ▼ -0.86 (-3.04%)
TBL 9.79 Decreased By ▼ -0.07 (-0.71%)
TELE 8.69 Decreased By ▼ -0.10 (-1.14%)
TPL 18.28 Increased By ▲ 0.04 (0.22%)
TPLP 13.45 Increased By ▲ 0.18 (1.36%)
TREET 22.53 Decreased By ▼ -0.19 (-0.84%)
TRG 59.85 Decreased By ▼ -0.29 (-0.48%)
World

Study finds 1 in 10 people in Spain has been infected with virus

  • The sero-prevalence study, presented late on Tuesday, is now in its fourth round. Its work involved carrying out rapid antibody tests on 51,409 people across the country of some 47 million people between November 16 and 29.
Published Updated
By

MADRID: Around 4.7 million people in Spain, which amounts to one in 10 people, have contracted the coronavirus since the start of the pandemic, according to a new government-led antibody study.

The figure is significantly higher than the health ministry official tally, which now sits at 1.76 million. It is higher too than the estimate of over three million Covid-19 cases announced by Prime Minister Pedro Sanchez in October.

The sero-prevalence study, presented late on Tuesday, is now in its fourth round. Its work involved carrying out rapid antibody tests on 51,409 people across the country of some 47 million people between November 16 and 29.

The results of the previous round of the study, published in July, found a prevalence rate of just over 5.0 percent.

The infection rate in Madrid was the highest of all Spanish regions, with around 18 percent of the population testing positive for Covid-19 antibodies, against the national rate of 9.9 percent.

In contrast, regions such as the Canary Islands and Valencia in the east had a prevalence rate below 5.0 percent.

Comments

Comments are closed for this article.